Supplemental Table 2. Multivariate logistic regression analysis predicting the 3-month outcomes.
| Multivariate logistic regression analysis* |
||||
|---|---|---|---|---|
| Model | Independent variable | OR | 95% CI | P Value |
| Model 1 (with MONO and HDL-C) | Age, y | 1.03 | 1.02–1.05 | 0.001 |
| Male | 1.66 | 1.13–2.43 | 0.010 | |
| Smoking | 1.34 | 1.03–1.71 | 0.026 | |
| Statin use history | 1.58 | 1.01–2.54 | 0.042 | |
| NIHSS score at Admission | 1.78 | 1.14–2.78 | 0.011 | |
| History of hypertension | 1.18 | 0.81–1.74 | 0.388 | |
| History of atrial fibrillation | 1.40 | 0.72–2.69 | 0.320 | |
| History of stroke | 1.52 | 1.02–2.27 | 0.039 | |
| History of CHD | 1.29 | 0.78–2.14 | 0.318 | |
| History of diabetes mellitus | 1.17 | 0.76–1.78 | 0.477 | |
| Neutrophil, 109/L | 1.11 | 1.02–1.20 | 0.016 | |
| TG, mmol/L | 0.81 | 0.65–1.01 | 0.057 | |
| MONO, 109/L | 2.21 | 1.05–4.68 | 0.038 | |
| HDL-C, mmol/L | 0.56 | 0.28–1.09 | 0.088 | |
| Model 2 (with MHR) | Age, y | 1.03 | 1.01–1.04 | 0.001 |
| Male | 1.38 | 0.96–1.99 | 0.084 | |
| Smoking | 1.27 | 1.01–1.65 | 0.016 | |
| Statin use history | 1.71 | 1.11–2.34 | 0.049 | |
| NIHSS score at Admission | 1.68 | 1.07–2.63 | 0.024 | |
| History of hypertension | 1.20 | 0.84–1.73 | 0.314 | |
| History of atrial fibrillation | 1.38 | 0.72–2.62 | 0.332 | |
| History of stroke | 1.30 | 0.89–1.90 | 0.184 | |
| History of CHD | 1.20 | 0.74–1.96 | 0.461 | |
| History of diabetes mellitus | 1.25 | 0.84–1.87 | 0.266 | |
| Neutrophil, 109/L | 1.17 | 1.09–1.25 | 0.001 | |
| TG, mmol/L | 0.81 | 0.66–0.99 | 0.043 | |
| MHR | 2.58 | 1.21–5.51 | 0.015 | |
NIHSS, National Institutes of Health Stroke Scale; CHD, coronary heart disease; WBC, white blood cell, MONO, monocyte; CHO, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein; HDL-C, high-density lipoprotein and MHR, monocyte to high-density lipoprotein ratio.